Brought to you by:
SVS Annual Business Meeting showcases 2024 Foundation award recipients
The Society for Vascular Surgery (SVS) convened its Annual Business Meeting at the Vascular Annual Meeting (VAM) on June 22 in Chicago. A highlight of the event was the announcement of the 2023–2024 award recipients by the outgoing Foundation Chair…
SVS Women’s Section delves into vascular trauma treatment intricacies amid ‘paucity of literature’
“Life over limb”—that was one of the key messages to emerge from the VAM 2024 SVS Women’s Section session that placed a lens over vascular trauma treatment. Misty Humphries, MD, associate professor of surgery at University of California Davis in…
Vascular care is a ‘team sport’ founded on infrastructure, personnel and standards
The E. Stanley Crawford critical issues forum at VAM 2024 in Chicago—which featured the tagline ‘Quality Care Everywhere’—underscored the importance of standards, infrastructure, personnel and verification programs in vascular surgery. Multiple speakers throughout the session described vascular care as a…
Government Grand Rounds: The role of stakeholders in legislative and administrative engagement
Stakeholder organizations such as the Society for Vascular Surgery (SVS) play a crucial role in shaping healthcare policies and ensuring that the voices of medical professionals are heard in the legislative and administrative processes. These organizations utilize several key methods…
Acellular tissue-engineered vessel granted FDA Regenerative Medicine Advanced Therapy designation for advanced PAD
Humacyte recently announced it has been granted Regenerative Medicine Advanced Therapy (RMAT) designation from the US Food and Drug Administration (FDA) for its investigational acellular tissue-engineered vessel (ATEV), designed to treat patients with advanced peripheral arterial disease (PAD). This RMAT…
Life Seal Vascular awarded NSF SBIR grant to advance sac management technology for EVAR
Life Seal Vascular recently announced that it has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant. The funding will be used to accelerate the development of the company’s endovascular aneurysm repair (EVAR) technology. “We are…
Grasping the nettle: The need to tackle PAD problem head on is huge, says 2024 Veith lecturer
Huge opportunities abound for vascular surgeons to take a leadership role on the frontlines of a developing peripheral arterial disease (PAD) treatment crisis in the U.S., says Michael Conte, MD, who gave the second annual Frank J. Veith Distinguished Lecture…
A calling seeded in childhood: Uniting vascular surgery for the betterment of patient care
Many attending the 2024 Vascular Annual Meeting (VAM; June 19–22) might have been unaware of the early life of 2023–24 Society for Vascular Surgery (SVS) President Joseph Mills, MD. Amongst an intrepid childhood following his father’s career as a dentist,…
The top 10 most popular Vascular Specialist stories of June 2024
In June, the most read stories from Vascular Specialist included key reports from the 2024 Vascular Annual Meeting (VAM; June 19–22) covering TEVAR, CEA vs TCAR, PAD and CFA-reintervention, among others; Linda Harris’ placement as SVS vice president; the relationship…
Sonovein FDA pivotal study treatments completed: Theraclion reaches key milestone on schedule
Theraclion, a French MedTech company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces today that treatments in the Food and Drug Administration (FDA) pivotal study for Sonovein, an extracorporeal medical device made to treat varicose veins using…